Sign In
Buy OM
$4.58
-0.0100 (-0.218%)
At Close: Jun 26, 2026
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
05:25am, Friday, 19'th Jun 2026
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
GENEVA--(BUSINESS WIRE)--OM Pharma Unveils the Largest Multi-Country Real-World Evidence Study on Broncho Vaxom® (OM 85) for RTI Prevention at EAACI 2026.
Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé
06:00am, Tuesday, 09'th Jun 2026
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") ( TSX: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce initial results from the 2
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
02:56pm, Friday, 05'th Jun 2026
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby y
Osisko Metals Files NI 43-101 Technical Report for the Gaspé Copper Project
07:19am, Friday, 29'th May 2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce the filing on SEDAR+ of a techni
Osisko Metals Announces Results of Voting at 2026 Annual Meeting of Shareholders and Welcomes Keith McKay to the Board
05:00pm, Thursday, 28'th May 2026
TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (TSX:OM "Osisko" or the "Corporation") announces the results of its annual meeting of shareholders (the "Meeting") held earlier tod
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 21'st May 2026
SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis wi
Outset Medical to Present at RBC Global Healthcare Conference
04:05pm, Monday, 11'th May 2026
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
02:11am, Saturday, 09'th May 2026
Outset Medical, Inc. (OM) Q1 2026 Earnings Call Transcript
Outset Medical Q1 Earnings Call Highlights
04:08pm, Friday, 08'th May 2026
Outset Medical NASDAQ: OM reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console utilization, new customer additions, gross margin expansi
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
07:01pm, Thursday, 07'th May 2026
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $3.24 per share a year ago.
Outset Medical Reports First-Quarter Results
04:02pm, Thursday, 07'th May 2026
SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis w
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
04:05pm, Monday, 27'th Apr 2026
SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcom
Contrasting EUDA Health (NASDAQ:EUDA) and Outset Medical (NASDAQ:OM)
02:38am, Monday, 27'th Apr 2026
EUDA Health (NASDAQ: EUDA - Get Free Report) and Outset Medical (NASDAQ: OM - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two compani
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
12:15pm, Monday, 13'th Apr 2026
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you
